您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报（医学版） ›› 2017, Vol. 55 ›› Issue (7): 100-102.doi: 10.6040/j.issn.1671-7554.0.2017.104

• 临床医学 • 上一篇    下一篇

前列腺绿激光汽化术治疗良性前列腺梗阻伴帕金森病的疗效

崔萌,郑冀鲁,田思男,李连军,张琦,金讯波,王慕文   

  1. 山东大学附属省立医院泌尿微创中心, 山东 济南 250014
  • 收稿日期:2017-01-25 出版日期:2017-07-10 发布日期:2017-07-10
  • 通讯作者: 王慕文. E-mail:wangmuwen@sdu.edu.cn E-mail:wangmuwen@sdu.edu.cn
  • 基金资助:
    国家自然科学基金(81572534);山东省科技攻关项目(2014GSF118165)

Photoselective vaporization of the prostate for the treatment of benign prostatic obstruction in patients with Parkinsons disease

CUI Meng, ZHENG Jilu, TIAN Sinan, LI Lianjun, ZHANG Qi, JIN Xunbo, WANG Muwen   

  1. Minimally Invasive Urology Center, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250014, Shandong, China
  • Received:2017-01-25 Online:2017-07-10 Published:2017-07-10

PDF (PC)

110

摘要： 目的 研究经尿道前列腺绿激光汽化术(PVP)治疗良性前列腺梗阻(BPO)伴帕金森病(PD)的疗效及安全性。 方法 选择2008年7月至2016年5月收治的BPO伴PD患者20例,65~75岁,平均(69.85±3.12)岁,平均国际前列腺症状评分(IPSS)(23.40±5.89)分,平均最大尿流率(Qmax)(5.75±1.71)mL/s。患者均出现排尿困难症状并确诊为BPO伴PD,均排除合并多系统萎缩病(MSA),采用配对t检验进行组间比较,评估行PVP手术的疗效。 结果 20例手术均顺利完成,平均手术时间(66.3±13.10)min,术后3个月患者平均IPSS(7.10±2.59)分,Qmax(14.03±4.40)mL/s,均较术前明显改善。4例患者术后出现急迫性尿失禁,经过盆底肌训练后好转。 结论 PVP是BPO伴PD患者解除尿路梗阻及改善症状的一种安全有效的治疗方法。

关键词: 帕金森病, 良性前列腺梗阻, 前列腺绿激光汽化术

Abstract: Objective To study the efficacy and safety of photoselective vaporization of the prostate(PVP)for the treatment of BPO in patients with PD. Methods A total of 20 patients with PD(excluding MSA)who underwent PVP for BPO were enrolled from July 2008 to May 2016. The average age was(69.85±3.12)years. The average IPSS was 23.40±5.89 and the average Qmax was(5.75±1.71)mL/s. All patients were diagnosed as BPO with PD for dysuresia. Paired t test for comparison was used to evaluate the efficacy of PVP between the groups. Results All 20 patients underwent the surgeries successfully. The average operation time, IPSS and Qmax at the 3 months after surgery were(66.3±13.10)minutes, 7.10±2.59 and(14.03±4.40)mL/s, respectively. Mild urge urinary incontinence occurred and voiding symptoms were improved after pelvic floor muscle training in 4 patients. Conclusion PVP is a safe and effective treatment for BPO in patients with PD.

Key words: Parkinsons disease, Photoselective vaporization of the prostate, Benign prostatic obstruction

中图分类号: 

  • R699
[1] Nunes RV, Manzano J, Truzzi JC, et al. Treatment of benign prostatic hyperplasia[J]. Rev Assoc Med Bras(1992), 2017, 63(2): 95-99.
[2] Tong YC. Which term to use: BPO or BPH?[J]. Low Urin Tract Symptoms, 2014, 6(2): 129.
[3] Sakakibara R, Panicker J, Finazzi-Agro E, et al. A guideline for the management of bladder dysfunction in Parkinsons disease and other gait disorders[J]. Neurourol Urodyn, 2016, 35(5): 551-563.
[4] 吴志刚, 沈丽霞. 帕金森病患者下尿路功能障碍治疗研究进展[J]. 神经药理学报, 2014,4(4):36-41. WU Zhigang, SHEN Lixia. Treatment for lower urinary tract dysfunction in patients with Parkinsons disease[J]. Acta Neuropharmacologica, 2014, 4(4): 36-41.
[5] Roth B, Studer UE, Fowler CJ, et al. Benign prostatic obstruction and parkinsons disease—should transurethral resection of the prostate be avoided?[J]. J Urol, 2009, 181(5): 2209-2213.
[6] Chen J, Wang M, Wang S, et al. 160-Watt lithium triboride laser vaporization versus transurethral resection of prostate: a prospective nonrandomized two-center trial[J]. Urology, 2012, 79(3): 650-654.
[7] Poewe W, Seppi K, Tanner CM, et al. Parkinson disease[J]. Nat Rev Dis Primers, 2017, 3(13): 1-21.
[8] Ravn AH, Thyssen JP, Egeberg A. Skin disorders in Parkinsons disease: potential biomarkers and risk factors[J]. Clin Cosmet Investig Dermatol, 2017, 10: 87-92. doi: 10.2147/CCID.S130319.
[9] Kapoor S, Bourdoumis A, Mambu L, et al. Effective management of lower urinary tract dysfunction in idiopathic Parkinsons disease[J]. Int J Urol, 2013, 20(1): 79-84.
[10] 薛芃, 韩志兴, 王涛. 64例帕金森病伴膀胱尿道功能障碍的临床分析[J]. 中华全科医学, 2011,9(10): 1519-1520. XUE Peng, HAN Zhixing, WANG Tao. Clinical analysis of Parkinsons disease with urinary bladder dysfunction: a report of 64 cases[J]. Chinese Journal of General Practice, 2011, 9(10): 1519-1520.
[11] Kim EH, Larson JA, Andriole GL. Management of benign prostatic hyperplasia[J]. Annu Rev Med, 2016, 67(8): 137-151.
[12] Macey MR, Raynor MC. Medical and surgical treatment modalities for lower urinary tract symptoms in the male patient secondary to benign prostatic hyperplasia: a review[J]. Semin Intervent Radiol, 2016, 33(3): 217-223.
[13] Staskin DS, Vardi Y, Siroky MB. Post-prostatectomy continence in the parkinsonian patient: the significance of poor voluntary sphincter control[J]. J Urol, 1988, 140(1): 117-118.
[14] Chandiramani VA, Palace J, Fowler CJ. How to recognize patients with parkinsonism who should not have urological surgery[J]. Br J Urol, 1997, 80(1): 100-104.
[15] Wyndaele JJ, Kovindha A, Igawa Y, et al. Neurologic fecal incontinence[J]. Neurourol Urodyn, 2010, 29(1): 207-212.
[16] Suchowersky O. Non-motor symptoms and parkinsonism[J]. Can J Neurol Sci, 2013, 40(1): 1-2.
[17] Krahn HP, Morales PA. The effect of pudendal nerve anesthesia on urinary continence after prostatectomy[J]. J Urol, 1965, 94(3): 282-285.
[18] Badri AV, Purohit RS, Skenazy J, et al. A review of lower urinary tract symptoms in patients with Parkinsons disease[J]. Curr Urol Rep, 2014, 15(9): 435-444.
[19] Chen B, Fan G, Sun W, et al. Usefulness of diffusion-tensor MRI in the diagnosis of Parkinson variant of multiple system atrophy and Parkinsons disease: a valuable tool to differentiate between them?[J]. Clin Radiol, 2017. doi: 10.1016/j.crad.2017.02.005.
[1] 勾云, 周波, 魏操,陈运华, 徐利,刘芬, 张春林, 文敏. 硫辛酸对帕金森病大鼠黑质线粒体的保护作用[J]. 山东大学学报（医学版）, 2017, 55(8): 18-23.
[2] 马翔宇,李卫国,陈思,陈腾,李超,徐硕,徐淑军,李新钢. 山东大学齐鲁医院神经外科脑深部电刺激术手术步骤标准化操作流程(SOP)暨核查表[J]. 山东大学学报（医学版）, 2017, 55(5): 117-121.
[3] 张文君,沈遥遥,戴庭敏,柴艺轩,涂江龙. 帕金森病并发喉痉挛1例[J]. 山东大学学报（医学版）, 2017, 55(5): 125-126.
[4] 王思,李秀华,杜鹃,岳龙涛,王瑶,刘菲,郭配. 侧脑室注射腺病毒介导的GDNF基因对帕金森病的保护作用[J]. 山东大学学报（医学版）, 2016, 54(4): 32-36.
[5] 杨璐, 周英泽, 倪明, 樊秀双, 满建梅, 郭军堂. β-synuclein对Ⅱ型囊泡单胺转移体表达的促进作用[J]. 山东大学学报（医学版）, 2015, 53(4): 61-64.
[6] 陈思, 王牧川, 任楠楠, 许巍, 王玲玲, 栾海辉, 马俊, 刘艺鸣. Parkin基因多态性与山东省汉族帕金森病发病风险的关系[J]. 山东大学学报（医学版）, 2015, 53(4): 71-74.
[7] 张忠霞, 马晓伟, 王彦永, 李晓丽, 王铭维. 帕金森病模型小鼠黑质纹状体系统氧化应激的增龄性改变[J]. 山东大学学报（医学版）, 2014, 52(9): 26-29.
[8] 张静1,暴丽华1,2,吴金涛1,李贵宝1,刘海莉1,岳庆伟1,朱德晓1,孙东1，宋守阳1，丁兆习1,孙晋浩1. 帕金森病肠功能分析及CXCR4在肠神经系统中的表达[J]. 山东大学学报（医学版）, 2014, 52(5): 25-29.
[9] 孟祥继，庞琦，丁锋，辛涛，杨洪安. 纹状体立体定向注射Taclo建立帕金森病大鼠模型[J]. 山东大学学报（医学版）, 2014, 52(3): 16-18.
[10] 曹伟，刘威，辛涛，庞琦. 纹状体定向注射TaClo介导的大鼠行为学改变及其黑质中cox-2的表达[J]. 山东大学学报(医学版), 2013, 51(11): 6-9.
[11] 周波1，文敏1，王赟2，龙高群3，瞿廷念3，李宏伟1，焦玲4，张春林3. 依达拉奉对帕金森病小鼠模型中脑细胞自噬的影响[J]. 山东大学学报(医学版), 2012, 50(8): 1-4.
[12] 陈思1，刘艺鸣1，任楠楠1，陈良1，李佳珍3，宁翔2，王京1. 散发性早发帕金森病PARK2基因突变及其临床特征[J]. 山东大学学报(医学版), 2012, 50(7): 55-59.
[13] 李恒1，李晓红2，毕建芬3，陈亚娜4. 全反式维甲酸促人脐血多能干细胞向多巴胺能神经元分化[J]. 山东大学学报(医学版), 2012, 50(6): 92-96.
[14] 李佳珍1，刘艺鸣1，吴林2，相媛媛3，张杨4，陈思1，任楠楠1. 美多芭与安坦对PD大鼠抑郁症状的影响[J]. 山东大学学报(医学版), 2011, 49(11): 30-33.
[15] 朱俊德,余资江,戈果. noggin对帕金森病大鼠黑质神经元的保护作用[J]. 山东大学学报(医学版), 2010, 48(2): 52-57.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发